NUSYRLIS Trademark

Trademark Overview


On Tuesday, January 29, 2019, a trademark application was filed for NUSYRLIS with the United States Patent and Trademark Office. The USPTO has given the NUSYRLIS trademark a serial number of 88281714. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 17, 2020. This trademark is owned by Menlo Therapeutics Inc.. The NUSYRLIS trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Pharmaceutical preparations for the treatment or prevention of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related conditions; diagnostic preparations for medical purposes; medical diagnostic reagents

Medical devices for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related conditions; medical devices for diagnosing viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related conditions
nusyrlis

General Information


Serial Number88281714
Word MarkNUSYRLIS
Filing DateTuesday, January 29, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 17, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 21, 2019

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment or prevention of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related conditions; diagnostic preparations for medical purposes; medical diagnostic reagents
Goods and ServicesMedical devices for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related conditions; medical devices for diagnosing viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related conditions

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 21, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, February 21, 2019
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMenlo Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRedwod City, CA 94063

Party NameMenlo Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRedwod City, CA 94063

Trademark Events


Event DateEvent Description
Monday, August 17, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 17, 2020ABANDONMENT - NO USE STATEMENT FILED
Thursday, December 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 17, 2019EXTENSION 1 GRANTED
Tuesday, December 17, 2019EXTENSION 1 FILED
Tuesday, December 17, 2019TEAS EXTENSION RECEIVED
Tuesday, July 16, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 21, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 21, 2019PUBLISHED FOR OPPOSITION
Wednesday, May 1, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 10, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 10, 2019ASSIGNED TO EXAMINER
Thursday, February 21, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, February 1, 2019NEW APPLICATION ENTERED IN TRAM